Stroke, Vol 21, 943-947, Copyright © 1990 by American Heart Association
C Scavini, A Rozza, P Bo, E Lanza, L Favalli, F Savoldi and G Racagni
Endogenous opioids have been shown to produce beneficial effects in
experimental stroke. To evaluate both neurophysiological and biochemical
parameters, we induced massive cerebral ischemia in 11 rabbits according to
the method standardized in our laboratory, using microspheres injected
through the internal carotid artery. Binding studies were performed in the
11 embolized, in nine control, and in five sham-operated rabbits using the
appropriate concentration of [3H]dynorphin A (1-8). Neurophysiological
parameters were evaluated under baseline conditions and 1 hour after
embolization, surgical preparation, or sham operation in 17 rabbits.
Comparison of visual readings of the electroencephalograms and analyses of
the quantified electroencephalograms under baseline conditions and after
embolization indicated a marked and statistically significant (p less than
0.01) increase in bilateral delta activity; histologic examination
confirmed bilateral brain edema. Binding studies on kappa-opioid receptors
indicate that 1 hour after embolization there were significantly more (28%)
kappa-opioid receptors (Bmax) in six embolized rabbits than in five
sham-operated animals. No significant changes were observed in the affinity
parameters, particularly in the dissociation constant (Kd). Our results
indicate a role for endogenous dynorphin peptides in the pathogenesis of
stroke.
ARTICLES
Kappa-opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits
Institute of Pharmacology and Neurologic Institute C. Mondino, University of Pavia, Italy.
This article has been cited by other articles:
![]() |
B. Yulug, E. Cam, A. Yildiz, and E. Kilic Buprenorphine Does Not Aggrevate Ischemic Neuronal Injury in Experimental Focal Cerebral Ischemia J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 331 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Clark, E. C. Raps, D. C. Tong, and R. E. Kelly Cervene (Nalmefene) in Acute Ischemic Stroke : Final Results of a Phase III Efficacy Study Stroke, June 1, 2000; 31(6): 1234 - 1239. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |